Respiratory Drugs Flashcards
Salmeterol, Formoterol, Indacaterol
Long acting B2 agonists that have an extended lipophilic side chain causing them to remain in tissue for an extended period of time; should only be used for prophylactic therapy and not acute attacks
Indacaterol ➡️ indicated for COPD
***Must prescribe anti-inflammatories to go with this drug
ADRs: Similar to short acting; corticosteroids will help prevent tolerance
Ipratropium, Tiotropium
Muscarinic antagonists that prevent the Ach stimulated increase in cGMP respiratory smooth muscle cells
Commonly used in combo w/ b2 agonists as they have mixed results alone; Ipratropium can be used for rhinitis
ADRs: Bitter taste, xerostomia, glaucoma if sprayed in eye
Theophylline
PDE inhibitor, adenosine-receptor antagonist, anti-inflammatory, and promotes contraction of diaphragm
-Commonly used on pts. whose asthma is not controlled by SABA/corticosteroid therapy; caffeine (another methylxanthine) can be given to preterm infants
CYP metabolized
ADRs: Low levels- N/V High levels- Seizure, arrhythmia
***LOW TI
Beclomethasone, Budesonide, Triamcinolone Acetate
MOA in respiratory disease: Anti-inflammatory by inhibiting production of prostaglandins and leukotrienes
*****UPREGULATE B2 RECEPTOR EXPRESSION
Commonly given as a combo inhaler w/ LABAs
-Indicated for acute exacerbations of asthma and severe COPD
ADRs: Dysphonia, oral/pharyngeal candidiasis
Albuterol, Terbutaline
Short acting B2 agonists; used to reverse asthmatic attacks
-Should only be used rarely (acutely), if it is used frequently, it indicates a need for anti-inflammatory therapy (glucocorticoids)
ADRs: Tremors, anxiety, tachycardia, tolerance (downregulation of B2 receptors)
Zafirlukast, Montelukast
MOA: Leukotriene receptor antagonists that inhibit bronchoconstriction and smooth muscle contraction
-Alternative to corticosteroids if they are not tolerated
ADRs: Hepatoxicity; Zafirlukast=CYP inhibitor; Montelukast=mildest
Zileuton
MOA: Inhibits lipooxygenase
Same uses as Zafirlukast and Montelukast
ADRs: SEVERE hepatotoxicity; fever, chills; CYP inhibition
Omalizumab
MOA: IgE antibody tht inhibits its binding to mast cells
-Effective therapy reserved for severe COPD not responding to other therapy
ADRs: Anaphylaxis
Drugs used for cough
Opiods (hydrocodone, codeine) that directly inhibit the cough center in the medulla and dextromorphan (inhibits NMDA receptors)
ADRs: Respiratory depression (bad for asthma), dysphoria, fatigue, addiction
Guaifenesin
Mucolytic drug that is used as an expectorant (Mucinex)
N-acetylcysteine
Mucolytic drug that cleaves disulfide bonds; indicated for acetaminophen OD, chronic bronchitis, and sometimes CF
Dornase alpha
DNAse that thins mucous and is the DOC for CF pts.
Oxymetazoline, pseudoephrine
Symptomatic adrenergic a-agonist that constrict swollen nasal mucosa
ADRs: Rebound nasal congestion, HTN, tachycardia, nausea
Benzonatate
Cough suppressant that works thru stimulation of peripheral vagal fibers
ADRs: Dizziness
Pneumoniae assoc. With effusions
Staph and strep